Platinum antitumor activity

Another report reveals, however, that in vitro DNA-binding assays are insufficient to predict platinum antitumor activity [15]. Primer extension (Fig. 1) was used to identify specific adducts formed by platinum complexes on DNA in HeLa cells. The DNA adduct profile correlated well with in vivo antitumor activity for cis- and trans-DDP, Pt(en)Cl2, and two acridine-tethered platinum complexes. When the complexes were allowed to react with purified DNA in solution, there were no substantial differences in adduct profiles between active and inactive compounds. This result demonstrates that cell-based assays can be better predictors of in vivo activity than in vitro assays, particularly when the in vitro screen does not require aunique, mechanism-based molecular interaction. 

Salts of neodecanoic acid have been used in the preparation of supported catalysts, such as silver neodecanoate for the preparation of ethylene oxide catalysts (119), and the nickel soap in the preparation of a hydrogenation catalyst (120). Metal neodecanoates, such as magnesium, lead, calcium, and zinc, are used to improve the adherence of plasticized poly(vinyl butyral) sheet to safety glass in car windshields (121). Platinum complexes using neodecanoic acid have been studied for antitumor activity (122). Neodecanoic acid and its esters are used in cosmetics as emoUients, emulsifiers, and solubilizers (77,123,124). Zinc or copper salts of neoacids are used as preservatives for wood (125). 

A.n log ue Synthesis. Two notable examples, in which analogues have greater therapeutic indexes than the parent dmgs, have been identified in Phase I trials. These are carboplatin (29) and ado2elesin (37) (35). Carboplatin s approval was based on its comparable efficacy to cis-platinum (28) and its more favorable toxicity profile, ie, reduced and delayed episodes of emesis, reduced ototoxicity, etc. On the other hand, ado2elesin, a totally synthetic analogue of natural product CC1065, has demonstrated a similar potency and antitumor activity profile as its natural prototype but is devoid of the delayed death UabiUty associated with the parent dmg in animals (36). 

Perez-Soler, R., Khokhar, A. R., Hacker, M. P., and Lopez-Berestein, G. (1986). Toxicity and antitumor activity of cis-bis-cyclopentenecarboxylato-1,2-diaminocyclohexane platinum(II) encapsulated in multilamellar vesicles. Cancer Res., 46. 6269-6273. 

The electronic spectra and magnetic susceptibility of [Ni(21)Cl2] were found to be consistent with a five-coordinate high spin complex. This complex has greater antitumor activity against P388 lymphocytic leukemia test system in mice than cobalt(II), copper(II), zinc(II) and platinum(II) complexes of 21 [187],... 

Since the discovery of the anticancer and antitumor activity of platinum complexes, there has been an effort to identify organic complexes of other metals that possess similar activities. Gielen and coworkers39 state that the antitumor activities of the di- -butyltin(TV) and diethyltin(IV) fluorobenzoates (FQdECOO SnlG and (FC6H4-C00SnR2)402, R = Et, Bu are satisfactory. 

Figure 1.6 The antitumor active platinum coumpound cw-dichlorodiammineplatinum(II).

Nonsymmetrical ligand substitution reactions also play an important role in a number of biological processes. One of these concerns the antitumor activity of platinum metal complexes, for which substitution processes involving DNA moieties are generally accepted to... 

VII. Antitumor Active Platinum-Blue Complexes References... 

Antitumor Activities of Platinum Compounds Against L1210 in Vivo... 

The greatest research effort on radiation sensitizers has focused on organic compounds however, platinum complexes conform to the hypotheses for radiation sensitizers since they are electron affinic and react preferentially with the hydrated electron in aqueous solution. Early studies of cisplatin in combination with radiation therapy suggested a synergistic effect in antitumor activity (50,51). Much of the initial data were obtained using cells in tissue culture (52), these data indicated that the potential of cisplatin to inhibit repair of radiation-induced damage to DNA could be an important contributor to the enhanced tumor cell killing seen in vivo by the combination of these two modes of treatment. 

Oxaliplatin (trans-L-diaminocyclohexane oxalate platinum II) was selected for development based on preclinical antitumor activity in murine leukemia lines and in colon cancer models (151,152). The clinical development of oxaliplatin has been primarily in colorectal cancer alone and in combination with 5-fluorouracil. 

Although there has heen a great deal of research concerning how platinum(II) complexes hind to biological molecules and the hkely mechanism of antitumor activity of these platinum-containing species, far less attention has heen paid to the properties of other metal complexes in this arena. Recent attention has fallen on cohalt(II)-Schiff hase complexes, as several have heen discovered to have promise as antiviral agents. A review of recent work has appeared elsewhere [64], so the topic will not he covered here however, in addition to focusing on recent developments, emphasis is placed on the introduction of the new head unit, 3,6-diformylpyridazine (13), into Schiff-hase macrocyclic electrochemistry. 

---